An Act To Eliminate the 2-year Limit on MaineCare Coverage for Approved Drugs for Opioid Use Disorder
Sec. 1. 22 MRSA §3174-SS, as enacted by PL 2011, c. 477, Pt. I, §1, is repealed.
Sec. 2. 22 MRSA §3174-UU, sub-§7, ¶D, as amended by PL 2013, c. 368, Pt. AAAAA, §1, is further amended to read:
This bill repeals the 24-month limit on MaineCare coverage or reimbursement for buprenorphine and naloxone combination drugs, also known as Suboxone, for the treatment of addiction to opioids.